An Observational Study on Epithelioid Sarcoma (EPISObs)

Italian Sarcoma Group

Status: Enrolling

Conditions: Epithelioid Sarcoma

Treatments: Other: Treatment for Epitheloid Sarcoma

Study type: Observational

Funder types: NETWORK

Identifiers

NCT03099681

ISG-EPISObs

Details and patient eligibility

About

Prospective Italian study aimed to provide a description of the population affected by Epithelioid Sarcoma (ES)

Full description

The present prospective national study aims to provide a description of the population affected by ES, an insight into the natural history of the disease and an answer some on the outstanding questions on its management. Also, it will focus on enhancing any differences between the two ES variants (classical-type and proximal-type) in order gain a better understanding of the disease, tailor the treatment and lastly improve outcome.

Enrollment: 100 estimated patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion criteria

1. Histological diagnosis of epithelioid sarcoma according to 2014 World Health Organization (WHO) classification, performed on biopsy or surgical specimen
2. Signed informed consent
3. Adequate patient compliance to treatment or follow up
4. No age limit

Exclusion criteria

1. Other malignancies within past 5 years, with exception of carcinoma in situ of the cervix and basocellular skin cancers treated with eradicating intent
2. Impossibility to ensure adequate compliance

Trial design

100 participants in 1 patient group

Epitheloid Sarcoma patients

Description:

Patients with diagnosis of localized or advanced epitheloid sarcoma seen in the Italian reference centers for sarcoma treatment that receive treatment for Epitheloid Sarcoma

Treatment:

Other: Treatment for Epitheloid Sarcoma